EUVIMEDEUVIMED entdecken
Crossref

Controllable Adaptive Molybdate‐Oligosaccharide Nanoparticles Regulate M2 Macrophage Mitochondrial Function and Promote Angiogenesis via PI3K/HIF‐1α/VEGF Pathway to Accelerate Diabetic Wound Healing

Xiuhong Huang iD, Liqin Zheng, Yueshan Zhou, Shaonan Hu, Wancheng Ning, Simin Li, Ziling Lin, Shaohong Huang

Advanced Healthcare Materials · 2024-01 · 13 (3)

DOI: 10.1002/adhm.202302256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 20.11.2023. Verfasst von Xiuhong Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Dentistry, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, 510280, China. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Diabetes Mellitus, Molybdenum. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Science Research Cultivation Program of Stomatological Hospital, Southern Medical University, GuangDong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The complex wound environment of diabetic wounds leads to poor treatment efficacy, and the inflammatory disorders and vascular injury are the primary causes of death in such patients. Herein, a sprayable, controllable adaptive, pH‐responsive nanosystem of molybdate and oligosaccharide (CMO) is specially developed as an immunomodulatory and angiogenesis‐promotion material for diabetic wound healing. CMO exhibited pH‐responsive release of Mo 2+ and oligosaccharide (COS), specifically in response to the alkalescent environment observed in diabetic wounds. CMO provide an anti‐inflammatory environment by promoting M2 polarization through significantly stimulating macrophage mitochondrial function. Specifically, CMO with a certain concentration reduce reactive oxygen species (ROS) and tumor necrosis factor α (TNF‐α) expression, and upregulated mitochondrial membrane potential (MMP), superoxide dismutase (SOD), and interleukin 10 (IL‐10) expression in macrophages. Moreover, CMO facilitate angiogenesis via upregulating the PI3K/HIF‐1α/VEGF pathway—a critical process for the formation of new blood vessels that supply nutrients and oxygen to the healing tissue. Remarkably, CMO promote cell viability and migration of endothelial cells, and enhance the expression of angiogenic genes. In vitro and in vivo studies suggest this simple but powerful nanosystem targeting mitochondrial function has the potential to become an effective treatment for diabetic wound healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor ADiabetes MellitusMolybdenumHumansPhosphatidylinositol 3-KinasesEndothelial CellsAngiogenesisWound Healing

Stichwörter der Autor:innen

PI3K/HIF-1α/VEGF pathwayangiogenesisdiabetic woundsmacrophagesmitochondrial functionmolybdate-oligosaccharide

Substanzen

Vascular Endothelial Growth Factor APhosphatidylinositol 3-KinasesmolybdateMolybdenum

Autor:innen und Institutionen

  • Department of Preventive Dentistry, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, 510280, China.
  • Department of The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
  • Department of Orthopedic Trauma, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.

ORCID-Profile: Xiuhong Huang

Förderung

  • China Postdoctoral Science Foundation
  • Science Research Cultivation Program of Stomatological Hospital, Southern Medical University
  • GuangDong Basic and Applied Basic Research Foundation

Zitieren

APA

Huang, X., Zheng, L., Zhou, Y., Hu, S., Ning, W., Li, S., Lin, Z., & Huang, S. (2024). Controllable Adaptive Molybdate‐Oligosaccharide Nanoparticles Regulate M2 Macrophage Mitochondrial Function and Promote Angiogenesis via PI3K/HIF‐1α/VEGF Pathway to Accelerate Diabetic Wound Healing. Advanced Healthcare Materials, 13(3). https://doi.org/10.1002/adhm.202302256

Vancouver

Huang X, Zheng L, Zhou Y, Hu S, Ning W, Li S, et al. Controllable Adaptive Molybdate‐Oligosaccharide Nanoparticles Regulate M2 Macrophage Mitochondrial Function and Promote Angiogenesis via PI3K/HIF‐1α/VEGF Pathway to Accelerate Diabetic Wound Healing. Advanced Healthcare Materials. 2024;13(3). doi:10.1002/adhm.202302256

BibTeX
@article{Huang2024,
  author = {Huang, Xiuhong and Zheng, Liqin and Zhou, Yueshan and Hu, Shaonan and Ning, Wancheng and Li, Simin and Lin, Ziling and Huang, Shaohong},
  title = {Controllable Adaptive Molybdate‐Oligosaccharide Nanoparticles Regulate M2 Macrophage Mitochondrial Function and Promote Angiogenesis via PI3K/HIF‐1α/VEGF Pathway to Accelerate Diabetic Wound Healing},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {3},
  doi = {10.1002/adhm.202302256}
}
Kostenlos starten →